Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Headache|October 3, 2020
No "Wearing-Off Effect" Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long-Term StudyAndrew M Blumenfeld, Darko M Stevanovic, Mario Ortega, et al.
Neurology and Therapy|August 5, 2023
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative ReviewAndrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, et al.
Headache|September 28, 2004
Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark StudyStewart J Tepper, Carl G H Dahlöf, Andrew Dowson, et al.
Headache|December 23, 2011
Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRIStewart J Tepper, Mark J Lowe, Erik Beall, et al.
Clinical Drug Investigation|January 18, 2022
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)Stewart J Tepper, Jessica Ailani, Janet H Ford, et al.
JAMA Neurology|December 20, 2021
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical TrialsMessoud Ashina, Peter J Goadsby, David W Dodick, et al.
The Journal of Headache and Pain|August 29, 2021
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTANRichard B Lipton, Simin K Baygani, Stewart J Tepper, et al.
Headache|January 18, 2023
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trialMessoud Ashina, Stewart J Tepper, Uwe Reuter, et al.
Headache|June 2, 2019
Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized TrialsStewart J Tepper, John H Krege, Louise Lombard, et al.
Clinical Therapeutics|October 31, 2015
Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical StudiesPaul Martin, Michael Gillen, David Millson, et al.
Pageof 21